Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen-Cilag International NV
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a diagnosis of schizophrenia (according to International Classification of Diseases \[ICD\]-10)
Be currently receiving PP3M and have previously received 4 to 6 injections of PP3M
Have the required language skills to participate in the online questionnaire, in the opinion of the physician
Be able and willing to provide their informed consent for study participation
You may not be if
Has received involuntary treatment with PP3M
Was switched to PP3M treatment within a clinical trial
Clareo Health | A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
